Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ALPINE IMMUNE SCIENCES, INC. | Chief Medical Officer | Stock Option (Right to buy) | 50K | Jan 5, 2023 | Direct | ||
Dermata Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 10K | Jan 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DRMA | Dermata Therapeutics, Inc. | Jan 4, 2024 | 1 | $0 | 4 | Jan 5, 2024 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 5, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Medical Officer |
DRMA | Dermata Therapeutics, Inc. | Oct 6, 2022 | 1 | $0 | 4 | Oct 7, 2022 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Aug 17, 2022 | 1 | $0 | 4 | Aug 18, 2022 | Chief Medical Officer |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Aug 17, 2022 | 0 | $0 | 3 | Aug 18, 2022 | Chief Medical Officer |
DRMA | Dermata Therapeutics, Inc. | Jul 7, 2022 | 1 | $0 | 4 | Jul 8, 2022 | Director |
DRMA | Dermata Therapeutics, Inc. | Apr 7, 2022 | 1 | $0 | 4 | Apr 8, 2022 | Director |
DRMA | Dermata Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
DRMA | Dermata Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 17, 2021 | Director |
DRMA | Dermata Therapeutics, Inc. | Aug 12, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Director |